(Q47218005)

English

Development and evaluation as vaccines in mice of Brucella melitensis Rev.1 single and double deletion mutants of the bp26 and omp31 genes coding for antigens of diagnostic significance in ovine brucellosis

scientific article published in July 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/15246618

Development and evaluation as vaccines in mice of Brucella melitensis Rev.1 single and double deletion mutants of the bp26 and omp31 genes coding for antigens of diagnostic significance in ovine brucellosis (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/15246618

Brucella melitensis

object named as

Brucella melitensis

1 reference

based on heuristic

inferred from title

Axel Cloeckaert

1

object named as

Axel Cloeckaert

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/15246618

author name string

Isabelle Jacques

2

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/15246618

Maria Jesus Grilló

3

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/15246618

Clara M Marín

4

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/15246618

Maggy Grayon

5

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/15246618

Jose-Maria Blasco

6

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/15246618

Jean-Michel Verger

7

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/15246618

language of work or name

0 references

publication date

1 July 2004

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/15246618

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/15246618

22

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/15246618

21-22

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/15246618

2827-2835

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/15246618

A review of the use of B. melitensis Rev 1 vaccine in adult sheep and goats

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.001

7 January 2021

An ELISA with Brucella lipopolysaccharide antigen for the diagnosis of B. melitensis infection in sheep and for the evaluation of serological responses following subcutaneous or conjunctival B. melitensis strain Rev 1 vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.001

7 January 2021

Antibody response to Brucella melitensis outer membrane antigens in naturally infected and Rev1 vaccinated sheep

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.001

7 January 2021

Production and characterisation of monoclonal antibodies to Brucella melitensis cytosoluble proteins that are able to differentiate antibody responses of infected sheep from Rev. 1 vaccinated sheep

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.001

7 January 2021

Identification of sero-reactive Brucella melitensis cytosoluble proteins which discriminate between antibodies elicited by infection and Rev. 1 vaccination in sheep

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.001

7 January 2021

Competitive enzyme-linked immunosorbent assay using monoclonal antibodies to the Brucella melitensis BP26 protein to evaluate antibody responses in infected and B. melitensis Rev.1 vaccinated sheep

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.001

7 January 2021

Comparison of three serological tests for Brucella ovis infection of rams using different antigenic extracts

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.001

7 January 2021

Development and validation of an indirect enzyme immunoassay for detection of ovine antibody to Brucella ovis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.001

7 January 2021

Characterization of an immuno-dominant antigen in Brucella ovis and evaluation of its use in an enzyme-linked immunosorbent assay

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.001

7 January 2021

Identification and characterization of immunodominant antigens during the course of infection with Brucella ovis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.001

7 January 2021

Identification and characterization of Brucella ovis immunogenic proteins using two-dimensional electrophoresis and immunoblotting.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.001

7 January 2021

Single-step purification and evaluation of recombinant BP26 protein for serological diagnosis of Brucella ovis infection in rams.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.001

7 January 2021

The Brucella abortus Lon functions as a generalized stress response protease and is required for wild-type virulence in BALB/c mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.001

7 January 2021

DNA polymorphism at the omp-31 locus of Brucella spp.: evidence for a large deletion in Brucella abortus, and other species-specific markers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.001

7 January 2021

Brucella melitensis Rev. 1 living attenuated vaccine: Stability of markers, residual virulence and immunogenicity in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.001

7 January 2021

In vitro markers and biological activity in mice of seed lot strains and commercial Brucella melitensis Rev 1 and Brucella abortus B19 vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.001

7 January 2021

Brucella suis S2, brucella melitensis Rev. 1 and Brucella abortus S19 living vaccines: residual virulence and immunity induced against three Brucella species challenge strains in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.001

7 January 2021

[Transformatinon normalizing the distribution of the number of Brucella organisms in the spleen of rats vaccinated intraperitoneally]

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.001

7 January 2021

Outer-membrane protein- and rough lipopolysaccharide-specific monoclonal antibodies protect mice against Brucella ovis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.001

7 January 2021

Identification of protective outer membrane antigens of Brucella ovis by passive immunization of mice with monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.001

7 January 2021

The recombinant Omp31 from Brucella melitensis alone or associated with rough lipopolysaccharide induces protection against Brucella ovis infection in BALB/c mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.001

7 January 2021

Induction of antibody and protective responses in mice by Brucella O-polysaccharide-BSA conjugate

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.001

7 January 2021

Brucella abortus vaccine strain RB51 produces low levels of M-like O-antigen.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.001

7 January 2021

Biological properties of RB51; a stable rough strain of Brucella abortus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.001

7 January 2021

Comparison of the efficacy of Brucella abortus strain RB51 and Brucella melitensis Rev. 1 live vaccines against experimental infection with Brucella melitensis in pregnant ewes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.001

7 January 2021

The Brucella abortus RB51 vaccine does not confer protection against Brucella ovis in rams

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.001

7 January 2021

Cloning of a Brucella melitensis group 3 antigen gene encoding Omp28, a protein recognized by the humoral immune response during human brucellosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.001

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative analyses of proteins extracted by hot saline or released spontaneously into outer membrane blebs from field strains of Brucella ovis and Brucella melitensis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.001

7 January 2021

based on heuristic

inferred from DOI database lookup

Cloning, nucleotide sequence, and expression of the Brucella melitensis omp31 gene coding for an immunogenic major outer membrane protein.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.001

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular characterization of a Brucella species large DNA fragment deleted in Brucella abortus strains: evidence for a locus involved in the synthesis of a polysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.001

7 January 2021

based on heuristic

inferred from DOI database lookup

Surface exposure of outer membrane protein and lipopolysaccharide epitopes in Brucella species studied by enzyme-linked immunosorbent assay and flow cytometry.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.001

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification of seven surface-exposed Brucella outer membrane proteins by use of monoclonal antibodies: immunogold labeling for electron microscopy and enzyme-linked immunosorbent assay

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.001

7 January 2021

based on heuristic

inferred from DOI database lookup

Effectiveness of natural and synthetic complexes of porin and O polysaccharide as vaccines against Brucella abortus in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.001

7 January 2021

based on heuristic

inferred from DOI database lookup

Serologic responses in diagnostic tests for brucellosis in cattle vaccinated with Brucella abortus 19 or RB51

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.001

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2004.01.001

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/15246618

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/15246618

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47218005&oldid=2146540142"